Related Experiment Video

Updated: Apr 30, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

PERM1 Is Selectively Restored in Left Ventricular Assist Device-Mediated Myocardial Recovery in Heart Failure

Karthi Sreedevi1,2, Thirupura S Shankar3, Alexey V Zaitsev1,2

  • 1Fralin Biomedical Research Institute at Virginia Tech Carilion Virginia Tech Roanoke VA USA.

Journal of the American Heart Association
|April 29, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
O‐GlcNAcylationPPARGC‐1 and ESRR‐induced regulatorcontractilityheart failureleft ventricular assist device (LVAD)muscle‐specific 1 (PERM1)myocardial recovery

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K

Related Experiment Videos

Last Updated: Apr 30, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790

Articles linked to this work by shared authors, journal, and citation graph.

Mitral Regurgitation After LVAD Weaning for Cardiac Recovery or LVAD-related Complications: A VAD Wean Recovery Network Report.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

A Recovery-Focused Framework for the Management of Cardiogenic Shock.

Circulation. Heart failure·2026

Microcurrent Therapy in Cardiac Repair: Bridging Mechanistic Biology and Clinical Evidence.

Circulation. Heart failure·2026

Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure.

Science (New York, N.Y.)·2026

Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure.

Research square·2026

Extracellular matrix and cytoskeletal reverse remodeling pathways are key drivers of myocardial recovery following left ventricular assist device therapy.

bioRxiv : the preprint server for biology·2026

Real-World External Validation of Artificial Intelligence-Based Full-Vessel Segmentation for Intracoronary Optical Coherence Tomography.

Journal of the American Heart Association·2026

Asian Computed Tomography Criteria for Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage: Magnetic Resonance Imaging and Pathology Validations.

Journal of the American Heart Association·2026

Health-Related Quality of Life in Adults With Congenital Heart Disease: A Population-Based Study.

Journal of the American Heart Association·2026

Ambient Carbon Monoxide as a Delayed Trigger of Acute Aortic Dissection: A Time-Stratified Case-Crossover Study in a Tropical Industrial Metropolis.

Journal of the American Heart Association·2026

Distinctive Features of Obstructive Sleep Apnea in Chinese Patients With Acute Cerebral Infarction: A Prospective Observational Study.

Journal of the American Heart Association·2026

Novel Prediction Model for ICU Admission in Acute Intracerebral Hemorrhage.

Journal of the American Heart Association·2026

Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in Infantile- vs. late-onset Pompe disease patients.

Frontiers in immunology·2026

Mitochondria-Targeted Nanozyme Reprograms Dendritic-Cell Immunometabolism via Microenvironment-Responsive CO Release to Treat Periodontitis.

Advanced healthcare materials·2026

Microaneurysm segmentation in early diabetic retinopathy: a localized patch-based U-Net approach to overcome microscopic lesion oversight.

International journal of retina and vitreous·2026

Routine microaxial left ventricular support during nonemergent high-risk PCI: an updated systematic review and meta-analysis with Bayesian and grade methodologies.

Expert review of medical devices·2026

Modified Hu-lu-ba-wan and its active component trigonelline ameliorate diabetic renal tubular injury via enhancing PACS2-regulated mitochondria-endoplasmic reticulum contacts and mitophagy.

Fitoterapia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us